technology: high value manufacturing

28
Driving Innovation Technology: High Value Manufacturing Robin Wilson Lead Technologist, High Value Manufacturing 29 th October 2009 UK Manufacturing Strategy Progress check - One Year On: NESTA, London 1

Upload: bisgovuk

Post on 23-Jan-2015

1.567 views

Category:

Technology


2 download

DESCRIPTION

Presentation by Robin Wilson, Lead Technologist, High ValueManufacturing, Technology Strategy Board.This was delivered at the Advanced Manufacturin Strategy: One Year Onevent held at NESTA, London on 29 October 2009.

TRANSCRIPT

Page 1: Technology: High value manufacturing

Driving Innovation

Technology: High Value Manufacturing

Robin WilsonLead Technologist, High Value Manufacturing29th October 2009

UK Manufacturing StrategyProgress check - One Year On: NESTA, London

1

Page 2: Technology: High value manufacturing

Driving Innovation

Pod 1 Pod 2 Pod 3 Pod 4 Pod 5

3.10-3.40

Global value chains - UKTI advanced engineeringDonald McNeil

Technology - High value manufacturing, Robin Wilson, Technology Strategy Board

Intangibles- Designing DemandDavid Godber, Design Council

Manufacturing Skills – an interactive session examining supply attraction and workforce development and then looking at skills for the future.Joanna Woolf, Cogent and Lynn Tomkins Semta

Low Carbon Industrial StrategyAdam Cartwright, Office for Low Emission Vehicles

3.50-4.10

UKTI – meet the companies exporting in and

Meet some of the companies who have been working successfully with TSB

Meet some of the companies where design has improved sales

Manufacturing the Future: Pat Langford, Director of Programmes, STEMNET will lead a discussion on promoting Manufacturing as an exciting and dynamic career choice. Meet a company who are working hard to inspire young people.

Meet companies who are operating successfully in low carbon markets

2

Page 3: Technology: High value manufacturing

Driving Innovation

Who are the Technology Strategy Board

• We are a national body set up to invest in business innovation

• We are sponsored by Department of Business, Innovation and Skills (BIS – our hosts today)

• We come from business (and the public sector)About 100 people, >1200 years of business experience

• We work across business, universities and Government

• We are responsible for investing £1bn3

Page 4: Technology: High value manufacturing

Driving Innovation

We support the full range of business

• We help strengthen the global competitive position of our leading businesses

• We identify and grow sectors and businesses with the capacity to become the best in the world

• We nurture the businesses that can succeed in the growth sectors of tomorrow

4

Page 5: Technology: High value manufacturing

Driving Innovation

And we make choices

• We don’t pick winners, we pick sectors where UK businesses can thrive and support innovative companies in them

• We consider the size of the markets, the capability of the UK to address them and the timing

• And the difference our support would make

5

Page 6: Technology: High value manufacturing

Driving Innovation

How we deliver

6

Page 7: Technology: High value manufacturing

Driving Innovation

Technology Inspired Innovation

• We build capability in the underpinning areas that enable a sure and effective response to market needs– Advanced materials

– Bioscience

– Electronics, photonics and electrical systems

– Information and communication technologies

– High value manufacturing

– Nanotechnology

7

Page 8: Technology: High value manufacturing

Driving Innovation

Our Tools for Prioritisation and Delivery

• Published Technology Strategies– To communicate funding priorities and rationale

• eg: High Value Manufacturing Strategy (Sept 2008)– To provide clear, consistent focus for funding applicants

• Competitions – collaborative R&D projects• eg: £24m High Value Mfg, launched January 2009

• Additional funding mechanisms• SBRI for R&D contracts (Government procurement)• Large (>£5m) CR&D Projects, assessed on individual basis

8

Page 9: Technology: High value manufacturing

Driving Innovation

Our Investment (Assessment) criteria

Can the UK do it?

Is there a large market opportunity?

Is the idea ‘ready’?

Can the Technology Strategy Board make a

difference?

Model for success: a convincing “yes” to these 4 questions

9

Page 10: Technology: High value manufacturing

Driving Innovation

Manufacturing Strategy

• Working with Industry

• Working with Academia

• Working with Government

• Working together

• Developing a common understanding of challenges and opportunities

• Prioritising investment in key areas

• Publish Strategy, launch CR&D competitions10

Page 11: Technology: High value manufacturing

Driving Innovation

ManufacturingThrough Life

• Not just production

• Interfaces forwards and backwards

HIGH VALUE MANUFACTURING

Research

Design &Development

Production

Sale

Service

Operation

Decommission

11

Page 12: Technology: High value manufacturing

Driving Innovation

We are world’s 6th largest manufacturer

12

Page 13: Technology: High value manufacturing

Driving Innovation

ProductsProductionProcesses

ServiceSystems

Value Systems

The Four ‘Pillars’ of the HVM Strategy

The strategy includes key manufacturing activities that enhance competitive advantage in high wage economies;

…and it recognises that large amounts of value-add and value-capture occur outside production –

…and that technology may bring innovation in all areas.

13

Page 14: Technology: High value manufacturing

Driving Innovation

Prioritisation .. in areas of high growth + high R&D intensity

Growth

R&

D I

nte

ns

ity

14

Page 15: Technology: High value manufacturing

Driving Innovation

High Value Manufacturing Competition

• The Step Change in Competitiveness / Value Systems Competition was launched in January 2009 and invited businesses in a broad range of industry sectors to form consortia and compete for funding.

• The aim was for companies to achieve major improvements of between 25% and 50% relative to their current performance in areas such as overall manufacturing costs, whole life-cycle costs, whole life environmental impact and product performance, durability and reliability. 

15

Page 16: Technology: High value manufacturing

Driving Innovation

January 09 Competition - metrics

• £24M – Step Change in Competitiveness and Value Systems

• Your Response– 500 downloads (enquiries)– 300+ EoIs (>£300M investment requested)– 87 Full Proposals assessed– 32 projects shortlisted for funding

16

Page 17: Technology: High value manufacturing

Driving Innovation

And the results – how the £24m was won

Sector/SIC Group Number of projects

TSB funding

(£m)

TSB Funding (%)

Bioscience & Healthcare 13 9.1 38

Special Purpose Machinery 8 4.9 20

Automotive 3 3.4 15

Aerospace 2 2.5 10

Electrical 1 1.1 5

Non Ferrous Metals 1 0.9 4

Construction 2 0.8 3

Agrochemicals 1 0.7 3

Environmental 1 0.6 3

Total 32 24 100 17

Page 18: Technology: High value manufacturing

Driving Innovation

Some of the Winning Consortia – here today at NESTA

SHIELD Project

Simon Collins

Pete Ellison

Tom Pinto

Venu Kumar    

BIOCHEMIST Project

 Kay McClean

CELL THERAPIES Project

Tina Crombie

 

 HEPTACORE Project

 Mike Whelan

 

RAPIDPART  Project

Russell Owen, Weir Valves

Peter Brown, TWI

STEP Project Keith Freebairn Professor Ian Sutherland

18

Page 19: Technology: High value manufacturing

Driving Innovation

Discussion

• Consortia members – you are our customers !

• Customer satisfaction?

• How did you hear about the competition?

• Is the subject scope (technology) right for you?

• Funding and timescales?

• What do we (TSB & BIS) do right?

• What could we improve on?

• Other contributions & feedback?

19

Page 20: Technology: High value manufacturing

Driving Innovation

SHIELD• Summary: The aim of project SHIELD is to develop novel acetabular and

femoral components that minimise bone resorption. This will be achieved through a combination of component design and material optimisation by which the load transfer from prosthesis to bone will attempt to mimic bone stress levels pre-operation. The objective is to develop an innovative solution to the problem of stress shielding in hip implants therefore increasing the efficacy of total hip prostheses by increased life span and a reduced need for revision surgery after failed implantation.

• Partners: – Corin Ltd (lead),

– Invibio Biomaterial Solutions Ltd,

– Durham University

– TWI Ltd,

– Imorphics Ltd,

– Continuum Blue Ltd.

20

Page 21: Technology: High value manufacturing

Driving Innovation

BIOCHEMIST• Title: Biocatalysis and Chemical Engineering for Manufacturing Intensification

and Sustainability - BIOCHEMIST

• Summary: This project will integrate all phases of bioprocess development from catalyst discovery and engineering, to process design, through to highly efficient small footprint manufacture of high value products - enhancing the efficiency, sustainability and flexibility of chemical manufacture. The principle objectives of the project are (a) a novel compact reactor system for efficient continuous chemical manufacture, (b) advanced process design to accelerate introduction of new bio-manufacturing processes and products (c) new competitive bioprocesses to prepare unnatural amino acids and chiral amines.

• Partners: – C -Tech Innovation Ltd (lead),

– Ashe Morris Ltd,

– Ingenza Ltd.

21

Page 22: Technology: High value manufacturing

Driving Innovation

STEP• Title: Scalable Technology for the Extraction of Pharmaceuticals - STEP

• Summary: We plan to develop small footprint, versatile, counter-current chromatography purification technology and methodology which can be operated at a range of scales in both batch and continuous modes and that can be inserted into existing process plant and systems. The consortium will address major production challenges aiming to provide a flexible, low capital capability driving substantial cost efficiency in both drug development and drug manufacturing processes.

• Partners: – GlaxoSmithKline Research and Development Ltd (lead)

– Brunel University

– Pfizer Limited

– Dynamic Extractions Ltd.

22

Page 23: Technology: High value manufacturing

Driving Innovation

MANUFACTURE OF CELL THERAPIES• Title: Advanced manufacturing process for the production of individualised

cell therapies

• Summary: Individualised cell therapies ("ICTs") for the treatment of cancer, autoimmune disease, and infectious disease are progressing through regulatory approval for clinical use. ICTs are generally based on natural or genetically enhanced immune cells with disease-fighting applications and are therefore distinct from regenerative stem cell therapies. This project aims to achieve the first advanced cell manufacturing system (the "CellPro Manufacturing System") to support the routine clinical use of ICTs on a cost-effective and convenient basis.

• Partners: – Cell Medica Ltd (lead)

– University College London,

– eXmoor pharma concepts ltd.

23

Page 24: Technology: High value manufacturing

Driving Innovation

RAPIDPART• Title: RapidPart - Significant Step Change in the Selective Laser Melting Powder

Bed Process for the Manufacture of High Value Components

• Summary: RapidPart will deliver step change reductions in the manufacturing cost of laser powder bed deposition, or Selective Laser Melting (SLM), by significantly increasing the speed of the process. The targeted 500% increase in processing speed will enable this high value, flexible and environmentally-friendly process to become commercially viable for a more widespread range of applications, giving the UK a technical advantage and world lead in laser additive manufacture.

• Partners: – Weir Valves and Controls UK Ltd (lead)

– TWI Ltd (Academic)

– Thinklaser Limited,

– MTT Technologies Ltd,

– SPI Lasers UK Limited

– Disenco Limited,

– Materialise UK.

24

Page 25: Technology: High value manufacturing

Driving Innovation

HEPTACORE• Title: Commercial manufacture of a novel dual hepatitis vaccine

(Hepatacore)

• Summary: The aim of this project is the further development and commercial manufacture of a tandem-core technology (TCT) vaccine candidate, such that a clinical trial may be undertaken. TCT allows the insertion of at least two different viral antigens into a single highly immunogenic recombinant protein. This results in a vaccine which can deliver immunity to two viruses simultaneously within the confines of a single construct. This project intends to manufacture commercially a combined hepatitis A and B vaccine (HAV/HBV).

• Partners: – iQur Ltd

– University College London

– Mologic Ltd.

25

Page 26: Technology: High value manufacturing

Driving Innovation

26

Page 27: Technology: High value manufacturing

Driving Innovation

Helping you stay competitive

• Manufacturing Strategy– We believe our September 2008 HVM strategy

(and the Government’s Manufacturing Strategy published at the same time) remain valid and relevant, in recession and for recovery.

• Additional Funding– £150m Advanced Mfg package (July, Gov’t)– £5m extension to HVM competition (July, TSB)– £1m Technology Inspired Feasibility (Sept, TSB)– Further TSB competitions with significant

manufacturing content planned for 2010.

27

Page 28: Technology: High value manufacturing

Driving Innovation

http://www.innovateuk.org

e: [email protected]: 01793 442938

28